Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

CIMT with or without a robotic glove to improve hand use in children with hemiplegic cerebral palsy

Official title: Effects of Constraint Induced Movement Therapy With and Without Robotic Glove on Dexterity and Hand Grip Strength in Children With Hemiplegic Cerebral Palsy

Run by Riphah International University · NCT07248735 · Data updated 2026-11-12

This project will see if adding a robotic glove to constraint-induced movement therapy helps children aged 6–12 with hemiplegic CP improve hand dexterity and grip strength.

More Child Development trials

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment34 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedOctober 29, 2025
Main results expectedJanuary 25, 2026
Study endsJanuary 30, 2026
Registry record updatedNovember 25, 2025
Trial IDNCT07248735 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 years with hemiplegic CP who meet CIMT motor criteria (up to 20° wrist extension, up to 10° thumb abduction, up to 10° finger extension), GMFCS level 1–2, MAC grade 2–3, and who can follow simple instructions are the intended participants.

Probably not a fit

Children with severe cognitive impairment, other neurological disorders such as epilepsy, those already enrolled in other intensive physical therapy programs, or those outside the specified age and motor-function criteria are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, two-arm trial enrolls 34 children with hemiplegic cerebral palsy and compares standard constraint-induced movement therapy (CIMT) alone to CIMT combined with a robotic glove that assists finger flexion, extension, and individual finger movements. Participants receive intensive six-hour therapy sessions three to five days per week over a four- to eight-week period. Primary outcomes include hand dexterity and grip strength measured before and after the intervention. The trial is conducted at a single clinical site and is sponsored by Riphah International University.

Why it matters

Potential benefit: If successful, adding a robotic glove to CIMT could increase affected-hand dexterity and grip strength and help children gain greater independence in daily activities.

How similar studies have gone: Constraint-induced movement therapy has proven benefits for hemiplegic CP, while combining CIMT with robotic-assisted gloves is a relatively new approach with limited but encouraging preliminary evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 6-12 years with Hemiplegic CP.
* Both Genders will be included.
* Fulfilling the CIMT criteria i.e. Up to 20 Degree Wrist Extension, up to 10 Degree
* Thumb Abduction and Up to 10 Degree Finger Extension.
* GMFCS level of 1 and 2.
* MAC Grade 2 and 3.
* Ability to understand and follow simple instructions.

Exclusion Criteria:

* Severe cognitive impairment or intellectual disability.
* Presence of other neurological disorders such as epilepsy.
* Children currently participating in other intensive physical therapy programs.

Where it's running

  • Imran Amjad
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.